SuperworthDanaher EPS DHR
Diluted earnings per share by quarter and over the last twelve months, from 2008.
- Last 12 months, to Jun 26, 2026
- $5.63
- Latest quarter, Q2 FY26
- $1.23
- +60% on a year earlier
- Fiscal year 2025
- $5.04
- −5% on the year before
Danaher's earnings per share was $5.63 over the twelve months to Jun 26, 2026, up 20% on a year earlier.
In its latest quarter, Q2 FY26, it was $1.23, up 60% on the same quarter a year before.
Over the five fiscal years to FY2025 it grew 1% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $5.04 | −5% |
| FY2024 | $5.28 | −17% |
| FY2023 | $6.39 | −34% |
| FY2022 | $9.65 | +12% |
| FY2021 | $8.62 | +77% |
| FY2020 | $4.87 | +20% |
| FY2019 | $4.05 | +9% |
| FY2018 | $3.73 | +6% |
| FY2017 | $3.53 | −4% |
| FY2016 | $3.66 | −23% |
| FY2015 | $4.76 | +31% |
| FY2014 | $3.63 | −4% |
| FY2013 | $3.80 | +13% |
| FY2012 | $3.36 | +8% |
| FY2011 | $3.11 | +18% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $1.23 | +60% | $5.63 | |
| Q1 FY26 | $1.45 | +10% | $5.17 | |
| Q4 FY25 | $1.68 | +13% | $5.04 | |
| Q3 FY25 | $1.27 | +13% | $4.85 | |
| Q2 FY25 | $0.77 | −37% | $4.70 | |
| Q1 FY25 | $1.32 | −9% | $5.15 | |
| Q4 FY24 | $1.49 | +3% | $5.28 | |
| Q3 FY24 | $1.12 | −26% | $5.24 | |
| Q2 FY24 | $1.22 | −18% | $5.63 | |
| Q1 FY24 | $1.45 | −25% | $5.90 | |
| Q4 FY23 | $1.45 | −52% | $6.39 | |
| Q3 FY23 | $1.51 | −28% | $7.93 |
Against its peers
Companies in Medical - Diagnostics & Research nearest Danaher's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| DHRDanaher | $5.63 | +20% a year |
| TMOThermo Fisher Scientific | $18.96 | +10% a year |
| AAgilent Technologies | $5.09 | +19% a year |
| IQVIQVIA | $8.06 | +17% a year |
| WATWaters | $4.01 | −64% a year |
| IDXXIDEXX Laboratories | $14.22 | +18% a year |
| ILMNIllumina | $5.38 | −32% a year |
| MTDMettler-Toledo International | $44.42 | +12% a year |
| DGXQuest Diagnostics | $9.41 | +18% a year |
| LHLabcorp | $12.09 | +33% a year |
| MEDPMedpace | $17.05 | +27% a year |
| Peer median | $10.75 |
Where Danaher ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Danaher
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.